Back to News
Market Impact: 0.4

BofA cuts Chewy stock price target on valuation to $40 from $46

CHWYBCSSMCIAPP
Corporate EarningsCorporate Guidance & OutlookAnalyst InsightsAnalyst EstimatesCompany FundamentalsConsumer Demand & RetailArtificial IntelligenceInvestor Sentiment & Positioning
BofA cuts Chewy stock price target on valuation to $40 from $46

Chewy reported Q4 revenue of $3.27B (in line) and EPS $0.27 vs $0.09 forecast, with 21.3M active customers and fiscal 2027 revenue guidance of $13.6B–$13.75B and EBITDA margin guidance of 6.6%–6.8% (beats Street). BofA cut its price target to $40 from $46 but kept a Buy, modeling FY27 revenue $13.73B and EBITDA $928M using a 17x EV/EBITDA; the stock trades at $26.94 (down 38% over six months, 45% below its 52-week high) with an EV/EBITDA of 33.61 and P/E of 55.26. Management cited automation (55% of items picked automatically) and potential >$50M in AI-related cost savings supporting margin expansion, and InvestingPro flags the shares as undervalued despite recent multiple compression.

Analysis

The operational leverage story is credible — automation and AI-driven fulfillment changes are asymmetric: modest incremental capital can meaningfully compress per-order variable costs and unlock multi-hundred-basis-point EBITDA expansion over 12–24 months if throughput scales as planned. That creates a bifurcated outcome where execution wins compound free cash flow rapidly, while execution missteps (service disruption, rollout delays) produce visible margin erosion and investor impatience. Veterinary clinics and other on-platform services are a structural LTV accelerator but also convert a low-capex marketplace into a more capital- and people-intensive healthcare business. If utilization and cross-sell ramp as modeled, stickier customers and higher gross margins on services could justify a premium multiple; conversely, below-target utilization or labor/regulatory cost shocks would compress profitably faster than pure retail revenues. The equity is trading like a binary growth/compounder: short-term catalysts (proof of AI savings, holiday order cadence, margin guide-ups) can re-rate the multiple quickly, while any sign of decelerating discretionary demand will likely reverse those gains. Secondary beneficiaries include vendors tied to on-prem AI and fulfillment automation — their orders are lumpy and tend to precede material margin improvement by a quarter or two, offering lead indicators for the thesis. From a portfolio-construction view, this is a conditional growth trade best sized as a tactical overweight with explicit hedges. Time horizons matter: watch 3–6 month operational readthroughs for rollout KPIs, 6–18 months for sustained margin delivery, and 18+ months for LTV realization from services expansion.